Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., March 13, 2017 -- ReWalk Robotics Ltd. (Nasdaq:RWLK) today announced that Larry Jasinski, Chief Executive Officer, will present at the Oppenheimer 27th Annual Healthcare Conference as follows:
| Date: | Wednesday, March 22, 2017 |
| Time: | 3:55 p.m. Eastern Daylight Time |
| Location: | The Westin Grand Central, New York, NY |
The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, via the Company’s website at: www.rewalk.com, under the Investors Section, or via the following link at: https://www.veracast.com/webcasts/opco/healthcare2017/08231104468.cfm.
About ReWalk Robotics Ltd.
ReWalk Robotics is an innovative medical device company that is designing, developing and commercializing exoskeletons allowing wheelchair-bound individuals to stand and walk once again. Our mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit http://www.rewalk.com.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel.
Contact: Lisa Wilson In-Site Communications, Inc. Investor Relations T: (212) 452-2793 E: [email protected]
